IgG4-related disease: a rare but treatable cause of refractory intracranial hypertension

Hypertrophic pachymeningitis secondary to IgG4-related disease is a rare but sometimes devastating cause of intracranial hypertension. It has the potential for an excellent response to corticosteroids or rituximab. We discuss the clinical presentation, imaging, histology (with its difficult distinction from lymphoma), management and follow-up of a case, including relapse and re-treatment following an initial response to rituximab.

[1]  J. Stone,et al.  IgG4-related disease , 2017, Current opinion in rheumatology.

[2]  Vikram Deshpande,et al.  The diagnostic utility of serum IgG4 concentrations in IgG4-related disease , 2014, Annals of the rheumatic diseases.

[3]  Seong-Hyun Park,et al.  Immunoglobulin G4-Related Hypertrophic Pachymeningitis with Skull Involvement , 2014, Brain tumor research and treatment.

[4]  R. Hebel,et al.  Overview of neurosarcoidosis: recent advances , 2014, Journal of Neurology.

[5]  J. Stone,et al.  IgG4-related hypertrophic pachymeningitis: clinical features, diagnostic criteria, and treatment. , 2014, JAMA neurology.

[6]  A. Kakita,et al.  Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. , 2014, Brain : a journal of neurology.

[7]  C. Briani,et al.  Diagnostic value of IgG4 Indices in IgG4-Related Hypertrophic Pachymeningitis , 2014, Journal of Neuroimmunology.

[8]  T. Sugiyama,et al.  Recurrence of IgG4-related disease following treatment with rituximab , 2013, Modern rheumatology.

[9]  J. Stone,et al.  IgG4-Related Disease and Hypertrophic Pachymeningitis , 2013, Medicine.

[10]  D. Sahani,et al.  Consensus statement on the pathology of IgG4-related disease , 2012, Modern Pathology.

[11]  S. Galetta,et al.  IgG4-related inflammatory pseudotumor of the central nervous system responsive to mycophenolate mofetil , 2012, Journal of the Neurological Sciences.

[12]  M. Lopes,et al.  IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria , 2010, Acta Neuropathologica.

[13]  Shaji K. Kumar,et al.  Immunophenotyping in multiple myeloma and related plasma cell disorders. , 2010, Best practice & research. Clinical haematology.

[14]  W. Heide,et al.  Cranial pachymeningitis: a rare neurological syndrome with heterogeneous aetiology , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[15]  J. Chan,et al.  IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. , 2009, American Journal of Surgical Pathology.

[16]  A. Mahadevan,et al.  Hypertrophic cranial pachymeningitis in countries endemic for tuberculosis: Diagnostic and therapeutic dilemmas , 2008, Journal of Clinical Neuroscience.

[17]  T. Nikaido,et al.  High serum IgG4 concentrations in patients with sclerosing pancreatitis. , 2001, The New England journal of medicine.

[18]  M. Rovaris,et al.  Central nervous system sarcoidosis--diagnosis and management. , 1999, QJM : monthly journal of the Association of Physicians.